Role of ErbB1 in the Underlying Mechanism of Lapatinib-Induced Diarrhoea: A Review
Sign Up to like & getrecommendations! Published in 2022 at "BioMed Research International"
DOI: 10.1155/2022/4165808
Abstract: Lapatinib, an orally administered small-molecule tyrosine kinase inhibitor (SM-TKI), is an effective treatment for ErbB2-positive breast cancer. However, its efficacy as one of the targeted cancer therapies has been hampered by several adverse effects, especially… read more here.
Keywords: review; erbb1; lapatinib; induced diarrhoea ... See more keywords
Lapatinib-induced inhibition of ovarian function is counteracted by the STAT3 pathway both in vivo and in vitro
Sign Up to like & getrecommendations! Published in 2021 at "Oncology Reports"
DOI: 10.3892/or.2021.8074
Abstract: Following the publication of the above article, the authors have realized that the same image had been selected to show H&E staining of the ovarian slices in the Control and 10 μM groups in Fig. 4A. After… read more here.
Keywords: ovarian function; induced inhibition; inhibition ovarian; lapatinib induced ... See more keywords